Latde Diagnostics

Latde Diagnostics

Sloan Siegrist, PhD
Co-Founder

Emily Melzer, PhD
CEO and Co-Founder

Carolina Santamaria
PhD Student

siegrist@microbio.umass.edu 
​​​​​​latdedx.com

Novel tools to direct life-saving, early decision-making for bacterial infections

Latde is developing a platform that produces a rapid, amplifiable readout for antibiotic susceptibility.

Current rapid antibiotic testing solutions are expensive, require expensive equipment, and therefore out of reach for most hospitals in the world.

Latde aims to reduce the duration and cost of pathogen detection and antibiotic susceptibility profiling, in turn saving lives, shortening hospital stays, containing hospital costs, and promoting antibiotic stewardship.

Associated Facility / Faculty / Staff
    • Associate Director for the Models to Medicine Center 

    M. Sloan Siegrist

    Department of Microbiology
    N271 Life Science Laboratories
    Amherst, MA 01003-9292

    (413) 545-2735
    siegrist@umass.edu
    umass.edu/microbiology/about/directory/m-sloan-siegrist

    • Collaboratories 
    • Startups